检索结果-南通市图书馆

The exploitation of epichloae endophytes for agricultural benefit

Fungal Diversity 2013年第3期60卷 171-188页

作者： Linda J.Johnson Anouck C.M.de Bonth Lyn R.Briggs John R.Caradus Sarah C.Finch Damien J.Fleetwood Lester R.Fletcher david E.Hume Richard D.Johnson Alison J.Popay Brian A.Tapper Wayne R.Simpson Christine R.Voisey Stuart D.Card AgResearch Ltd Grasslands Research CentreTennent DrivePalmerston North 4442New Zealand AgResearch Ltd Ruakura Research CentreEast StreetHamilton 3214New Zealand AgResearch Ltd Lincoln Research CentreCorner Springs Road and Gerald StreetLincoln 8140New Zealand AgResearch Laboratory of Structural Biology School of Biological SciencesUniversity of Auckland3a Symonds StreetAuckland 1142New Zealand Grasslanz Technology Ltd Tennent DrivePalmerston North 4474New Zealand

Epichloae endophytes of family Clavicipitaceae(comprising genera Epichloëand Neotyphodium)are fungal symbionts of Pooideae *** associations formed,range from mutually beneficial to antagonistic and the nature of this relationship is dependent upon the importance of vertical(via host seeds)versus horizontal(ascospore mediated)transmission of the *** endophytes can enhance their hosts’survival through protection from abiotic and biotic stresses and can thus be utilized in an agricultural ***-safe grass-endophyte associations that confer bio-protective properties for increased pasture persistence and productivity have been developed and *** of the crucial drivers underpinning the selection of epichloae strains for commercial development is endophyte derived *** potential of next generation endophytes is determined by testing a number of attributes such as agronomic fitness,animal and food safety as well as compatibility with host plants of *** research supports these activities by focusing on elucidating mechanisms of compatibility between host and fungal symbiont,as well as investigating other molecular drivers of symbiosis such as siderophore mediated iron-uptake,fungal signalling,fungal growth in host plants and fungal secondary *** review weaves together the different strands of multidisciplinary research aimed at ultimately exploiting epichloae endophytes for increased pasture performance.

关键词： Epichloë Neotyphodium Pooideae Symbiosis Secondary metabolite Toxicology

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

CONSORT 2010说明与详述:报告平行对照随机临床试验指南的更新

引用

中西医结合学报 2010年第8期8卷 701-741页

作者： david Moher Sally Hopewell Kenneth F Schulz Victor Montori Peter C Gφtzsche P J Devereaux Diana Elbourne Matthias Egger Douglas G Altman 周庆辉卞兆祥刘建平 Ottawa Methods Centre Clinical Epidemiology ProgramOttawa Hospital Research InstituteOttawa HospitalOttawaOntario Centre for Statistics in Medicine University of Oxford Wolfson College Family Health International Research Triangle Park UK Knowledge and Encounter Research Unit Mayo Clinic Rochester The Nordic Cochrane Centre Rigshospitalet Blegdamsvej 9 McMaster University Health Sciences Centre Hamilton Medical Statistics Unit London School of Hygiene and Tropical Medicine Institute of Social and Preventive Medicine (ISPM) University of Bern

大量证据显示随机对照临床试验(randomised controlled trial,RCT)的报告质量不理想。报告不透明,则读者既不能评判试验结果是否真实可靠,也不能从中提取可用于系统综述的信息。最近的方法学分析表明,报告不充分和设计不合理与对治疗效... 详细信息

大量证据显示随机对照临床试验(randomised controlled trial,RCT)的报告质量不理想。报告不透明,则读者既不能评判试验结果是否真实可靠,也不能从中提取可用于系统综述的信息。最近的方法学分析表明,报告不充分和设计不合理与对治疗效果产生评价偏倚有关。这种系统误差对RCT损害严重,而RCT正是以其能减少或避免偏倚而被视为评价干预措施的金标准。为了提高RCT的报告质量,一个由专家和编辑组成的工作组制定了临床试验报告的统一标准(Consolidated Standards of Reporting Trials,CONSORT)声明。CONSORT声明于1996年首次发表,并于2001年更新。声明由对照检查清单和流程图组成,供作者在报告RCT时使用。许多核心医学期刊和主要国际性编辑组织都已认可CONSORT声明。该声明促进了对RCT的严格评价和解释。2001年,在对CONSORT进行修订时,人们就已经清楚地认识到,解释和说明制定CONSORT声明的原理,有助于研究人员等撰写或评价临床试验报告。一篇CONSORT说明与详述文章于2001年同2001版CONSORT声明一起发表。2007年1月的专家会议之后,对CONSORT声明作了进一步修订并已发表,即"CONSORT2010声明"。这次更新对原版对照检查清单作了文字上的修改,使其更为明晰,并收入了与一些新近才认识到的主题相关的建议,如选择性报告结局产生的偏倚。说明与详述文件旨在加强人们对CONSORT声明的理解、应用和传播,这次也作了大量修订,对每一项新增或更新的清单条目的含义和增改理由进行了解释,提供了优秀的报告实例,还尽可能地提供了相关的经验性研究的参考文献。文中收入了若干流程图实例。"CONSORT2010声明"、其说明与详述文件,以及相关网站(***),对于改进随机临床试验报告必将有所裨益。

关键词：临床试验随机对照试验指南 CONSORT

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

红送裂纹机理分析

红送裂纹机理分析

引用

2019年炼钢生产新工艺、新技术、新产品研讨会

作者： Elliot Biro Joydeep Sengupta Manh-Kha Trinh Eva Dillon david Colbert 唐杰民 ArcelorMittal Global R&D hamilton ArcelorMittal Dofasco Inc.

阿赛洛米塔尔Dofasco有限公司具有两条板卷生产线,见图1简图。长流程为一台氧气转炉+精炼炉+VD真空炉+板坯连铸机1CC。有些钢种需脱气而配置了VD真空炉。短流程为一台双炉壳电弧炉+精炼炉+板坯连铸机2CC。两条线均可生产超低碳,低碳钢,中

关键词：翘皮缺陷精炼炉加热炉铸坯表面温度红送裂纹机理分析

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures？

引用

World Journal of Emergency Medicine 2011年第4期2卷 272-278页

作者： Samuel George Campbell R. Andrew McIvor Vincent Joanis david Graydon Urquhar Department of Emergency Medicine Charles V Keating Emergency and Trauma Centre 1796 Summer St Halifax NovaScotia B3H3A7 Canada (Campbell SG Urquhart DG) T2127 Firestone Institute for Respiratory Health St. Joseph′sHealth Care Hamilton Hamilton ON. L8N 4A6 Canada (McIvor RA) Foothills Medical Centre 1403 - 29th Street N.W.University of Calgary Calgary Alberta Canada (Joanis V)

BACKGROUND： Blood cultures （BC ） are commonly ordered during the initial assessment ofpatients with community-acquired pneumonia （CAP）, yet their yield remains low. Selective use of BCwould allow the opportunity to save healthcare resources and avoid patient discomfort. The studywas to determine what demographic and clinical factors predict a greater likelihood of a positiveblood culture result in patients diagnosed with ***： A structured retrospective systematic chart audit was performed to comparerelevant demographic and clinical details of patients admitted with CAP, in whom blood culture resultswere positive, with those of age, sex, and date-matched control patients in whom blood cultureresults were ***： On univariate analysis, eight variables were associated with a positive BC *** logistic regression analysis, however, the only variables statistically significantly associatedwith a positive BC were WBC less than 4.5 x 109/L [likelihood ratio （LR）： 7.75, 95% CI=2.89-30.39], creatinine 〉106 !mol/L （LR： 3.15, 95%CI=1.71-5.80）, serum glucose〈6.1 mmol/L （LR： 2.46,95%CI=1.14-5.32）, and temperature 〉 38 °C （LR： 2.25, 95% CI =1.21-4.20）. A patient with all of thesevariables had a LR of having a positive BC of 135.53 （95% CI=25.28-726.8） compared to patientswith none of these ***： Certain clinical variables in patients with CAP admitted to hospitals doappear to be associated with a higher probability of a positive yield of BC, with combinations of thesevariables increasing this likelihood. We have identified a subgroup of CAP patients in whom bloodcultures are more likely to be useful.

关键词： Community-acquired pneumonia Blood cultures

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Multiple quantitative trait loci contribute to resistance to bacterial canker incited by Pseudomonas syringae *** in kiwifruit(Actinidia chinensis)

引用

Horticulture Research 2019年第1期6卷 471-488页

作者： Jibran Tahir Stephen Hoyte Heather Bassett Cyril Brendolise Abhishek Chatterjee Kerry Templeton Cecilia Deng Ross Crowhurst Mirco Montefiori Ed Morgan Andrew Wotton Keith Funnell Claudia Wiedow Mareike Knaebel Duncan Hedderley Joel Vanneste John McCallum Kirsten Hoeata Amardeep Nath david Chagné Luis Gea Susan E.Gardiner The New Zealand Institute for Plant and Food Research Limited Private Bag 11030Manawatu Mail CentrePalmerston North 4442New Zealand The New Zealand Institute for Plant Food Research Limited HamiltonNew Zealand The New Zealand Institute for Plant and Food Research Limited Private Bag 92–169Auckland 1025New Zealand New Plant via Malpighi 5Forlì47122Italy The New Zealand Institute for Plant and Food Research Limited LincolnNew Zealand The New Zealand Institute for Plant and Food Research Limited 412 No 1 RoadRD2Te Puke 3182New Zealand

Pseudomonas syringae ***(Psa)biovar 3,a virulent,canker-inducing pathogen is an economic threat to the kiwifruit(Actinidia spp.)industry *** commercially grown diploid(2×)*** *** is more susceptible to Psa than tetraploid and hexaploid *** information on the genetic loci modulating Psa resistance in kiwifruit is not *** we report mapping of quantitative trait loci(QTLs)regulating resistance to Psa in a diploid kiwifruit population,derived from a cross between an elite Psa-susceptible‘Hort16A’and a resistant male breeding parent *** high-density genetic maps and intensive phenotyping,we identified a single QTL for Psa resistance on Linkage Group(LG)27 of‘Hort16A’revealing 16–19%phenotypic variance and candidate alleles for susceptibility and resistance at this *** addition,six minor QTLs were identified in P1 on distinct LGs,exerting 4–9%*** in the F1 population is improved by additive effects from‘Hort16A’and P1 QTLs providing evidence that divergent genetic pathways interact to combat the virulent Psa *** different bioassays further identified new QTLs for tissue-specific responses to *** genetic marker at LG27 QTL was further verified for association with Psa resistance in diploid Actinidia chinensis *** analysis of Psa-resistant and susceptible genotypes in field revealed hallmarks of basal defense and provided candidate RNA-biomarkers for screening for Psa resistance in greenhouse conditions.

关键词： breeding trait

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

血浆置换和糖皮质激素治疗抗中性粒细胞胞质抗体相关性血管炎:临床实践指南

引用

英国医学杂志中文版 2022年第12期25卷 703-711页

作者：曾力楠 Michael Walsh Gordon H Guyatt Reed A C Siemieniuk david Collister Michelle Booth Paul Brown Lesha Farrar Mark Farrar Tracy Firth Lynn A Fussner Karin Kilian Mark A Little Thomas A Mavrakanas Reem A Mustafa Maryam Piram Lisa K Stamp 肖瑛琪 Lyubov Lytyn Thomas Agoritsas Per O Vandvik Alfred Mahr 刘峥(译) 徐佩佩(译) 张伶俐(校) 四川大学华西第二医院药学部/循证药学中心成都中国 Department of Health Research Methods Evidence and ImpactMcMaster UniversityHamiltonOntarioCanada Population Health Research Institute McMaster UniversityHamiltonOntarioCanada Department of Medicine McMaster UniversityHamiltonOntarioCanada St.Joseph′s Healthcare HamiltonOntarioCanada USA UK Division of Pulmonary Critical Careand Sleep MedicineDepartment of Internal MedicineThe Ohio State University Wexner Medical CenterColumbusOhioUSA Department of Rheumatology Oslo University HospitalOsloNorway Institute of Clinical Medicine University of OsloOsloNorway Trinity Translational Medicine Institute Trinity College DublinIreland Irish Centre for Vascular Biology Tallaght University HospitalDublinIreland Department of Medicine McGill University Health CentreMontrealQuebecCanada Department of Internal Medicine Division of Nephrology and HypertensionUniversity of Kansas Medical CenterKansasUSA CHU Sainte Justine Research Center Department of PediatricsUniversity of MontrealMontrealQuebecCanada CEREMAIA Centre d′épidémiologie et de santédes populations(CESP)University Paris-SaclayLe Kremlin BicêtreFrance University of Otago Christchurch ChristchurchNew Zealand 四川大学华西护理学院/华西医院护理部成都中国 Division of General Internal Medicine&Division of Clinical Epidemiology University Hospitals of GenevaGenevaSwitzerland Department of Medicine Lovisenberg Hospital TrustOsloNorway Rheumatology Clinic Department of Internal MedicineKantonsspital St GallenSt GallenSwitzerland 四川大学华西第二医院药学部四川大学华西第二医院循证药学中心国家药品监督管理局药物制剂体内外相关性技术研究重点实验室出生缺陷与相关妇儿疾病教育部重点实验室四川大学华西临床医学院四川大学华西医院中国循证医学中心

对于抗中性粒细胞胞质抗体(antineutrophil cytoplasmic antibody,ANCA)相关性血管炎(ANCA-associated vasculitis,AAV)患者,血浆置换的作用是什么?接受治疗前6个月糖皮质激素的最佳剂量是多少?一项新发表的随机对照试验(randomised con... 详细信息

关键词：血浆置换抗中性粒细胞胞质抗体临床实践指南最佳剂量糖皮质激素 ANCA 随机对照试验 AAV

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

需要以专业技能为基础的随机对照试验

引用

英国医学杂志中文版 2005年第3期8卷 182-185页

作者： PJ Devereaux Mohit Bhandari Mike Clarke Victor M Montori Deborah J Cook Salim Yusuf david L Sackett Claudio S Cina SD Walter Brian Haynes Holger J Schunemann 许群 Department of Clinical Epidemiology and Biostatistics，McMaster University，1200 Main Street，West hamilton ON，Canada L8N 3Z5

外科手术不大可能像药物治疗那样严格的以证据为基础，因为其难以随机化分组。因此，以专业技能为基础的试验可能是今后发展的方向。

关键词：随机对照试验专业技能临床医生非药物干预外科手术随机分配试验设计

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

钠-葡萄糖共转运蛋白-2抑制剂或胰高血糖素样肽-1受体激动剂治疗成人2型糖尿病:临床实践指南

引用

英国医学杂志中文版 2021年第9期24卷 523-531页

作者： Sheyu Li Per Olav Vandvik Lyubov Lytvyn Gordon H Guyatt Suetonia C Palmer Rene Rodriguez-Gutierrez Farid Foroutan Thomas Agoritsas Reed A C Siemieniuk Michael Walsh Lawrie Frere david J Tunnicliffe Evi V Nagler Veena Manja Bjφrn Olav Asvold Vivekanand Jha Mieke Vermandere Karim Gariani Qian Zhao Yan Ren Emma Jane Cartwright Patrick Gee Alan Wickes Linda Fems Robin Wright Ling Li Qiukui Hao Reem A Mustafa 无郭鹤鸣(译) Chengdu China Chinese Evidencebased Medicine Center Cochrane China Center and MAGIC China CenterWest China HospitalSichuan UniversityChengduChina University of Oslo OsloNorway MAGIC Evidence Ecosystem Foundation Department of Health Research Methods Evidence and ImpactMcMaster UniversityHamiltonONCanada Department of Medicine McMaster UniversityHamiltonONCanada Department of Medicine University of OtagoChristchurchNew Zealand Plataforma INVEST Medicina UANL-KER Unit(KER Unit Mexico) Subdireccion de InvestigacionUniversidad Autonoma de Nuevo LeonMonterrey64460Mexico Knowledge and Evaluation Research Endocrinology Mayo ClinicRochesterMN55905USA Endocrinology Division Department of Internal MedicineUniversity Hospital"Dr.Jose E.Gonzalez"Universidad Autonoma de Nuevo LeonMonterrey64460Mexico Ted Rogers Center for Heart Research Canada Service of Endocrinology DiabetesNutrition and Patient Therapeutic EducationGeneva University HospitalsGenevaSwitzerland Newbridge Surgery BathUK Sydney School of Public Health The University of SydneySydneyAustralia Centre for Kidney Research The Children's Hospital at WestmeadSydneyAustralia Renal Division Ghent University HospitalBelgium University of California Davis USA Department of Endocrinology Clinic of MedicineSt Olavs HospitalTrondheim University HospitalTrondheimNorway K.G.Jebsen Center for Genetic Epidemiology Department of Public Health and NursingNTNUNorwegian University of Science and TechnologyTrondheimNorway The George Institute for Global Health UNSWIndia School of Public Health Imperial CollegeLondonUK Prasanna School of Public Health Manipal Academy of Higher EducationManipalIndia Department of Public Health and Primary Care KU LeuvenLeuvenBelgium International Medical Center/Ward of General Practice West China HospitalSichuan UniversityChengduChina London UK Founder&CEHD iAdvorateInc.VirginiaPatient partner Patient partner The Center of Gerontology and Geriatrics/National Clinical Research Center for Geriatr

临床问题对于存在不同心血管风险及肾脏结局的2型糖尿病患者,在原有生活方式干预和/或其他降糖药物的基础上加用钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂和胰高血糖素样肽1(GLP-1)受体激动剂的获益及风险是什么?现行做法几十年来,2型糖尿病... 详细信息

临床问题对于存在不同心血管风险及肾脏结局的2型糖尿病患者,在原有生活方式干预和/或其他降糖药物的基础上加用钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂和胰高血糖素样肽1(GLP-1)受体激动剂的获益及风险是什么?现行做法几十年来,2型糖尿病的治疗决策都以控制血糖为主导。SGLT-2抑制剂和GLP-1受体激动剂在传统观念中常被用于二甲双胍治疗后血糖仍控制不佳的患者。目前这一现状已经发生了改变,这得益于多项临床研究结果。研究显示SGLT-2抑制剂和GLP-1受体激动剂拥有独立于药物降糖作用之外的对于动脉粥样硬化性心血管病(CVD)和慢性肾脏病(CKD)的获益。建议本指南阐述了针对不同风险分层的成人2型糖尿病患者使用SGLT-2抑制剂或GLP-1受体激动剂的建议。•伴有3种或更少的心血管风险因素且不存在CVD或CKD:不建议启动SGLT-2抑制剂或GLP-1受体激动剂治疗。(推荐等级:弱)•伴有3种以上心血管风险因素且不存在CVD或CKD:建议启动SGLT-2抑制剂治疗,不建议启动GLP-1受体激动剂治疗。(推荐等级:弱)•已经存在CVD或CKD:建议启动SGLT-2抑制剂治疗和GLP-1受体激动剂治疗。(推荐等级:弱)•已经存在CVD和CKD:建议启动SGLT-2抑制剂治疗(推荐等级:强)和GLP-1受体激动剂治疗。(推荐等级:弱)•对于那些想要进一步降低CVD和CKD结局风险的患者:推荐优先启用SGLT-2抑制剂治疗而非GLP-1受体激动剂治疗。(推荐等级:弱)这项指南是如何制订的一个由患者、临床医生和方法学家共同组成的国际小组提出了这些推荐意见。这些推荐意见基于可信度较高的指南的标准,并使用GRADE分级方法进行评估。该小组采用了息者个体化的观点。证据一项关于获益与风险的系统综述和网络meta分析(764项随机对照研究,包括421346例参与者)发现SGLT-2抑制剂和GLP-1受体激动剂可以降低总体死亡率、心肌梗死发生率、终末期肾病或肾衰竭的发生率(中等至高等质量的证据)。在不同的亚组中这些药物对卒中、因心力衰竭所致住院和其他主要不良事件有不同的影响。药物绝对获益的程度因患者个体风险的不同有很大的差异。(例如,对于接受了超过5年药物治疗的1000例患者,在最低风险人群中死亡人数减少了5人,在最高风险人群中死亡人数减少了48人)。一项关于预后的综述确认了14种风险预测模型,其中一种(RECODe)在证据总结中报告了大部分基线风险评估数据,小组利用该模型以支持风险分层的建议。考虑到患者的价值观及个体差异,指南推荐的支撑证据包括一项对已发表论文的系统综述、一项患者焦点小组研究、一项临床问题总结,以及一项指南调查。指南解读我们依据不同的CVD和CKD风险水平,综合考虑获益、风险和其他因素的平衡,以及每一个风险组别的实际问题,来对推荐意见进行分层。本指南强烈建议CVD和CKD患者使用SGLT-2抑制剂治疗,这说明专家组认为其具有显著的获益。而对于其他成人2型糖尿病患者,推荐等级较弱,这说明专家组想要在获益、风险及治疗花费上取得一个更好的平衡。临床医生通过该指南可以使用可靠的风险计算模型,如RECODe,来明确其患者的个体心血管和肾脏疾病风险。医患交互式总结临床证据和制订决策有助于患者知晓治疗选择,包括进行共同决策。2型糖尿病人群(全球患病率不断增长1-2)正面临着不断增加的心血管疾病、肾脏病和其他并发症的风险3。数十年来,2型糖尿病的管理始终以控制血糖及糖化血红蛋白(HbA1c)为治疗目标4-5,但是,最近的高质量随机对照研究已经对这种以血糖为中心的治疗模式发起了挑战。研究结果显示,强化血糖控制未必会降低大血管不良事件,它还可能带来不利影响监管机构现在要求新型糖尿病药物必须证明其具有心血管和肾脏获益才能获得批准。对两类新药--钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂和胰高血糖素样肽1(GLP-1)受体激动剂(见框图1)的临床试验结果显示,在现有治疗方案(常规治疗)之上加用这些药物,对死亡、心肌梗死、卒中、心力衰竭和肾脏的结局(如进展为终末期肾病)都有获益8-12。

关键词：胰高血糖素样肽1 终末期肾病临床研究结果心血管风险 meta分析临床试验结果临床证据控制血糖

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

改进实效型试验的报告质量：CONSORT声明的扩充（1）

引用

英国医学杂志中文版 2009年第2期12卷 108-111页

作者： Merrick Zwarenstein Shaun Treweek Joel J Gagnier Douglas G Altman Sean Tunis Brian Haynes Andrew D Oxman david Moher 汪谋岳(译) Health Services Sciences Sunnybrook Hospital Toronto Ontario Canada Institute for Clinical Evaluative Sciences Toronto Depamnent of Health Policy Management and Evaluation University of Toronto Toronto Division of International Health (IHCAR) Karolinska Institute Stockholm Sweden Clinical and Population Sciences and Education University of Dundee Dundee Norwegian Knowledge Centre for the Health Services Oslo Norway Faculty of Medicine University of Toronto Centre for Statistics in Medicine University of Oxford Oxford Center for Medical Technology Policy Baltimore MD USA Division of General Internal Medicine Johns Hopkins School of Medicine Baltimore MD Center for Heahhcare Policy Stanford University School of Medicine Palo Alto CA USA Department of Clinical Epidemiology and Biostatistics and Department of Medicine McMaster University Faculty of Health Sciences Hamilton ON Canada Clinical Epidemiology Program Ottawa Health Research Institute Ottawa Canada Department of Epidemiology and Community Medicine Faculty of Medicine University of Ottawa Ottawa 中华医学杂志英文版编辑部

实效型试验旨在为临床实践决策提供依据，但报告得不好会降低其实用性。CONSORT和Practihc小组描述了对CONSORT指南的修改，帮助读者评估研究结果的适用性。

关键词： CONSORT声明报告质量试验临床实践适用性

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

改进实效型试验的报告质量：CONSORT声明的扩充（2）

引用

英国医学杂志中文版 2009年第3期12卷 174-179页

作者： Merrick Zwarenstein Shaun Treweek Joel J Gagnier Douglas G Altman Sean Tunis Brian Haynes Andrew D Oxman david Moher 汪谋岳(译) Health Services Sciences Surmybrook Hospital Toronto Ontario Canada Insdtute for Clinical Evaluative Sciences Toronto Department of Health Policy Management and Evaluation University of Tomato Toronto Division of International Health (IHCAR) Karolinska Institute Stockholm Sweden Clinical and Population Sciences and Education University of Dundee Dundee Norwegian Centre for Services Oslo Norway Faculty of Medicine University of Tomato Centre for Statistics in Medicine University of Oxford Oxford Center for Medical Technology Policy Baltimore MD USA Division of General Internal Medicine Johns Hopkins School of Medicine Baltimore MD Center for Healthcare Policy Stanford University School of Medicine Palo Alto CA USA Department of Medicine McMastor University Faculty of Health Sciences Hamilton ON Canada Clinical Epidemiology Program Ottawa Health Research institute Ottawa Canada Department of Epidemiology and Community Medicine Faculty of Medicine University of Ottawa Ottawa 中华医学杂志英文版编辑部

关键词： CONSORT声明报告质量试验临床实践适用性

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：